Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
60 participants
OBSERVATIONAL
2007-01-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Immuno-Response to Primary Cryotherapy for the Treatment of Prostate Cancer
NCT02250014
Prostate Conformal Cryotherapy
NCT00877682
Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer
NCT00295802
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer
NCT05454488
MR-Guided Cryoablation of Prostate Bed Recurrences
NCT01727284
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational
Patients with locally recurrent prostate cancer that have chosen salvage cryotherapy
Cryoablation / Cryotherapy
Salvage Cryoablation of the prostate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cryoablation / Cryotherapy
Salvage Cryoablation of the prostate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Undergone salvage cryotherapy of the prostate for recurrent prostate cancer
Exclusion Criteria
* Patients with clinically confirmed distant metastasis (unless deemed beneficial by the treating physician)
* Any previous major rectal surgery
* Clinically significant lower urinary tract or rectal anomalies
* Existing urethral, rectal, or bladder fistulae
30 Years
80 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Scientific Corporation
INDUSTRY
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Al Barqawi, MD
Role: STUDY_CHAIR
University of Colorado, Denver
David Crawford, MD
Role: STUDY_CHAIR
University of Colorado, Denver
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Loma Linda University
Loma Linda, California, United States
Kaiser Permanente
Sacremento, California, United States
Prostate Institute of America
Ventura, California, United States
University of Colorado at Denver and Health Sciences Center
Aurora, Colorado, United States
Lakeland Regional Cancer Center
Lakeland, Florida, United States
Rush University Medical Center
Chicago, Illinois, United States
Midwest Urology/RMD Clinical Research
Melrose Park, Illinois, United States
Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
Methodist Hospital
Brooklyn, New York, United States
Nelson Stone (private practice)
New York, New York, United States
Riverside Urology, Inc.
Columbus, Ohio, United States
Rhode Island Hospital/Warren Alpert Medical School of Brown University
Providence, Rhode Island, United States
Medical University of South Carolina
Charleston, South Carolina, United States
University of Tennessee Cancer Institute - Memphis
Memphis, Tennessee, United States
Urology Associates of North Texas
Arlington, Texas, United States
Urology of Virginia, Sentara Medical Group
Norfolk, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06-1040
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.